Stay updated with breaking news from Docusign Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DocuSign (NASDAQ:DOCU – Get Free Report) and Oncology Pharma (OTCMKTS:ONPH – Get Free Report) are both business services companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends. Volatility and Risk DocuSign has a beta of […]
Oncology Pharma (OTCMKTS:ONPH – Get Free Report) and DocuSign (NASDAQ:DOCU – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, risk, earnings and dividends. Analyst Recommendations This is a summary of recent ratings […]
Robeco Institutional Asset Management B.V. lowered its stake in DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 54.8% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 327,100 shares of the company’s stock after selling 397,214 shares during the quarter. Robeco Institutional […]
/PRNewswire/ -- Docusign (Nasdaq: DOCU) today announced that its first quarter fiscal 2025 results will be released on Thursday, June 6, 2024, after the close...
On May 1, 2024, Allan Thygesen, President and Chief Executive Officer of DocuSign Inc (NASDAQ:DOCU), executed a sale of 8,086 shares of the company.